If you missed BIO 2012, you missed a lot. The public and private sector came together this week on Boston to examine innovation opportunities to promote economic growth through collaborative research and development projects. The event drew 16,505 industry leaders from 49 states and 65 countries. Boston was host to universities, researchers, state, local and federal government economic development representatives, clinicians and private industries. This was science at its best at a truly global event. Discussions around where the biotech industry is going and how pharma is changing took center stage most of the week.
A positive trend was noted in a special state of bioscience development report that analyzes state and national biotech employment patterns. Despite job losses in the U.S. private sector, it showed that US biotech industry actually added jobs between 2001 and 2010. Throughout the week multiple conversations and meetings took place discussing how the ability to collaborate was a key element to attracting biotech projects. Many countries visited the Cisco booth to discover what they needed to do to create an infrastructure to welcome biotech development. How can governments work together with biotech companies to produce and atmosphere that welcomes and fosters innovation?